Uncategorized

Regulatory News: Innate Pharma SA announced members of its executive team are scheduled to participate in the upcoming conferences, detailed below.

Santhera Pharmaceuticals published the invitation to its Annual General Meeting, which will be held on June 18, 2024, at 10:00 CEST at Haus der Wirtschaft, Hardstrasse 1, 4133 Pratteln, Switzerland.

RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform signed a master service agreement with Daiichi Sankyo Co., Ltd.

Innovent Biologics, Inc. announced that picankibart, a recombinant anti-interleukin 23p19 subunit antibody injection, has met all the primary endpoints and key secondary endpoints in the Phase 3 registrational study in Chinese subjects with moderate to severe plaque psoriasis.

Until compelling surface targets for lung cancer are developed, antibody-drug conjugates will fail to treat most patients with lung cancer, experts told BioSpace.

With medicine becoming more specialized and clinical trial protocols increasingly complex, we need to think about how to drive efficiencies to overcome these challenges and keep up the pace of research.

Following a series of clinical failures, optimism builds for the first disease-modifying treatment.

Approaches and targets for depression and other mental health illnesses have remained stagnant for decades. With several readouts for novel therapies on the horizon, that could be changing.

Es una acumulación de aire fuera del pulmón pero dentro de la cavidad pleural

  A poco que hayas buscado por internet o hayas oído hablar, seguro que sabes que los seguros de decesos se encuentran entre los seguros más populares. La gran mayoría de las personas que deciden contratar seguros tienen un seguro de decesos para su mayor tranquilidad. …